Cramer Weighs In On Cytokinetics, LegalZoom And Matterport

On CNBC's "Mad Money Lightning Round," Jim Cramer said Cytokinetics, Inc. CYTK is a very good spec. Big pharma needs these companies, he added.

LegalZoom. com Inc LZ is going nowhere fast and you can't touch it because it has no backing on Wall Street, said Cramer.

3D cameras are very, very hot, but they're too hot for Cramer. He would take a pass on Matterport Inc MTTR.

Posted In: CNBCJim Cramermad money Lightning RoundMedia